Abstract:Free fatty acid (FFA)-induced hepatic lipotoxicity plays a pivotal role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Inhibition of FFA-associated hepatic toxicity represents a potential therapeutic strategy. Recently, it was reported that FFA-induced hepatic injury is closely linked to the ER stress response and autophagy activities. Glycyrrhizin (GL), the major bioactive component of licorice root extract, is a traditional Chinese medicine and has been used to treat hepatitis to reduce liver inflammation and hepatic injury for many years. However, the underlying cellular mechanism responsible for its positive clinical effects has not been elucidated. 18β-glycyrrhetinic acid (GA) is the biologically activemetabolite of GL. We have previous reported that GA prevents FFA-induced hepatic lipotoxicity by stabilization of lysosomal membrane and inhibition of cathepsin B expression and enzyme activity in hepatocytes. Our preliminary studies indicate that palmitic acid (PA) dose-dependently activates the ER stress response in hepatocytes. The aim of the current study was to determine whether GA prevents PA-induced hepatic injury through modulating ER stress response and autophagy activities in hepatocytes. Methods: Rat primary hepatocytes were treated with 0.25 mM PA in the presence of GA (0-10 μM) for various time periods. The intracellular lipid accumulation was detected by nile red staining. The expression levels of ER stress marker genes (GRP78, CHOP, XBP-1, ATF-4) were determined by real-time RTPCR and Western blot analysis. Activation of autophagy was determined by measuring the conversion of microtubule-associated protein 1 light chain 3 (LC3) without or with 2 htreatment of lysosomal inhibitors using Western blot analysis. The mRNA expression levels of key genes involved in hepatic lipid metabolism were assessed using real-time RT-PCR. Lentiviral shRNA was used to knock down GRP78 expression. Results: In rat primary hepatocytes, GA increased GRP78 mRNA and protein levels by 53% and 28%, respectively, over control cells. In addition, GA induced autophagy activities and reduced intracellular lipid accumulation. Furthermore, GA significantly reduced the expression of SREBP-1/ SREBP-2-target genes, i.e. fatty acid synthase (FAS), stearoyl-CoA desaturase 1 (SCD-1), 3hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoAR), and LDL receptor (LDL-R). GAmediated protective effect against PA-induced hepatic lipotoxicity was eliminated by downregulation of GRP78 expression using lentiviral shRNA. Conclusion: FFA-induced hepatic lipotoxicity is strongly related to the activation of hepatic ER stress. Regulation of GRP78 expression may represent an important mechanism by which GA prevents PA-induced hepatic lipotoxicity.

Glycyrrhetinic acid attenuates disturbed vitamin a metabolism in non-alcoholic fatty liver disease through AKR1B10

Glycine-β-muricholic acid antagonizes the intestinal farnesoid X receptor-ceramide axis and ameliorates NASH in mice

Niacin Ameliorates Hepatic Steatosis by Inhibiting De Novo Lipogenesis Via a GPR109A-Mediated PKC-ERK1/2-AMPK Signaling Pathway in C57BL/6 Mice Fed a High-Fat Diet

Ganoderic Acid A Ameliorates Non-Alcoholic Streatohepatitis (NASH) Induced by High-Fat High-Cholesterol Diet in Mice

Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation

Prevention of Free Fatty Acid-Induced Hepatic Lipotoxicity by 18Beta-Glycyrrhetinic Acid Through Lysosomal and Mitochondrial Pathways.

Glycyrrhizic acid ameliorates hepatic fibrosis by inhibiting oxidative stress via AKR7A2

Prevention of Free Fatty Acids/high Fat Diet‐induced Hepatic Lipotoxicity by 18β Glycyrrhetinic Acid

A Retinoic Acid Receptor Β2 Agonist Attenuates Transcriptome and Metabolome Changes Underlying Nonalcohol-Associated Fatty Liver Disease

Glycyrrhizic Acid Improving the Liver Protective Effect by Restoring the Composition of Lactobacillus

Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function

Γ-Linolenic Acid Prevents Lipid Metabolism Disorder in Palmitic Acid-Treated Alpha Mouse Liver-12 Cells by Balancing Autophagy and Apoptosis Via the LKB1-AMPK-mTOR Pathway.

Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease

Alanyl-Glutamine Dipeptide Attenuates Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice by Improving Gut Microbiota Dysbiosis

Protective effects of glycyrrhizic acid from edible botanical glycyrrhiza glabra against non-alcoholic steatohepatitis in mice.

Impaired Hepatic Vitamin A Metabolism in NAFLD Mice Leading to Vitamin A Accumulation in Hepatocytes

695 18ß-Glycyrrhetinic Acid Prevents Free Fatty Acid-Induced Hepatic Lipotoxicity by Upregulating GRP78 Expression

Modulation of Gut Microbiota by Glycyrrhizic Acid May Contribute to Its Anti-Nafld Effect in Rats Fed a High-Fat Diet.

Gallic Acid Ameliorated Impaired Lipid Homeostasis in a Mouse Model of High-Fat Diet—and Streptozotocin-Induced NAFLD and Diabetes through Improvement of β-oxidation and Ketogenesis

Rhapontigenin Improves Non-alcoholic Fatty Liver Disease by Inducing Lipophagy Through the ACOX1 and mTOR/ULK1 Pathways

Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism